Global cancer statistics, 2012
2015/02/04 by Lindsey A. Torre, Freddie Bray, Rebecca L. Siegel +3 · 27,391 citations
Medicine · #Cancer #Colorectal Cancer Screening and Detection #Esophageal Cancer Research and Treatment #Global Cancer Incidence and Screening #Internal medicine #Medicine #Statistics
paper · pdf · doi:10.3322/caac.21262
published in CA A Cancer Journal for Clinicians 65(2), 87-108 (Wiley)
openalex publication_date 2015/02/04 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/05
Abstract
Cancer constitutes an enormous burden on society in more and less economically developed countries alike. The occurrence of cancer is increasing because of the growth and aging of the population, as well as an increasing prevalence of established risk factors such as smoking, overweight, physical inactivity, and changing reproductive patterns associated with urbanization and economic development. Based on GLOBOCAN estimates, about 14.1 million new cancer cases and 8.2 million deaths occurred in 2012 worldwide. Over the years, the burden has shifted to less developed countries, which currently account for about 57% of cases and 65% of cancer deaths worldwide. Lung cancer is the leading cause of cancer death among males in both more and less developed countries, and has surpassed breast cancer as the leading cause of cancer death among females in more developed countries; breast cancer remains the leading cause of cancer death among females in less developed countries. Other leading causes of cancer death in more developed countries include colorectal cancer among males and females and prostate cancer among males. In less developed countries, liver and stomach cancer among males and cervical cancer among females are also leading causes of cancer death. Although incidence rates for all cancers combined are nearly twice as high in more developed than in less developed countries in both males and females, mortality rates are only 8% to 15% higher in more developed countries. This disparity reflects regional differences in the mix of cancers, which is affected by risk factors and detection practices, and/or the availability of treatment. Risk factors associated with the leading causes of cancer death include tobacco use (lung, colorectal, stomach, and liver cancer), overweight/obesity and physical inactivity (breast and colorectal cancer), and infection (liver, stomach, and cervical cancer). A substantial portion of cancer cases and deaths could be prevented by broadly applying effective prevention measures, such as tobacco control, vaccination, and the use of early detection tests.
Citations
Cited by
- Cancer statistics in China, 2015
- Treatment of muscle‐invasive and advanced bladder cancer in 2020
- Cancer statistics for Asian Americans, Native Hawaiians, and Pacific Islanders, 2016: Converging incidence in males and females
- EGR1-Mediated Transcription of lncRNA-HNF1A-AS1 Promotes Cell-Cycle Progression in Gastric Cancer
- A digital score of peri‐epithelial lymphocytic activity predicts malignant transformation in oral epithelial dysplasia
- Triggering the Antitumor Activity of Acyclic Enediyne through Maleimide-Assisted Rearrangement and Cycloaromatization
- N-methyl-N-nitro-N-nitrosoguanidine-mediated ING4 downregulation contributed to the angiogenesis of transformed human gastric epithelial cells
- Effectiveness of FDG-PET/CT for evaluating early response to induction chemotherapy in head and neck squamous cell carcinoma
- Effect of surgery-induced acute muscle wasting on postoperative outcomes and quality of life
- Major Depression and Survival in People With Cancer
- SNHG3 regulates NEIL3 via transcription factor E2F1 to mediate malignant proliferation of hepatocellular carcinoma
- Enhanced real-time pose estimation for closed-loop robotic manipulation of magnetically actuated capsule endoscopes
- Breast Cancer Screening for Women at Average Risk
- The role of mTOR in ovarian Neoplasms, polycystic ovary syndrome, and ovarian aging
- The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases
- European Society for Medical Oncology (ESMO) position paper on supportive and palliative care
- LvHemB1, a novel cationic antimicrobial peptide derived from the hemocyanin of Litopenaeus vannamei, induces cancer cell death by targeting mitochondrial voltage-dependent anion channel 1
- A phase III randomized study of first-line NUC-1031/cisplatin vs. gemcitabine/cisplatin in advanced biliary tract cancer
- The role of natural language processing in improving cancer care: A scoping review with narrative synthesis
- NLRC3 silencing accelerates the invasion of hepatocellular carcinoma cell via IL‐6/JAK2/STAT3 pathway activation
- miR-30d-5p inhibits proliferation, invasion and migration of breast cancer cells by targeting SERPINE1 and promoting fatty acid β-oxidation
- Patient Perspectives on Telemonitoring during Colorectal Cancer Surgery Prehabilitation
- Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatments
- Incidence, Risk Factors, and Prognosis of Patients with Hepatocellular Carcinoma and Brain Metastases
- Beyond endocrine resistance: estrogen receptor (ESR1) activating mutations mediate chemotherapy resistance through the JNK/c-Jun MDR1 pathway in breast cancer
- The effect of organized breast cancer screening on mammography use: Evidence from France
- MicroRNA‐1 overexpression increases chemosensitivity of non‐small cell lung cancer cells by inhibiting autophagy related 3‐mediated autophagy
- Multiview convolutional neural networks for lung nodule classification
- Colorectal cancer—global burden, trends, and geographical variations
- Metastatic patterns do not provide additional prognostic information for patients with FIGO stage IV high‐grade serous ovarian cancer
- Laparoscopic distal gastrectomy for clinical stage I gastric adenocarcinoma: Techniques evolution and oncological outcomes of the first 100 cases
- Circ-IGF1R Affects the Progression of Colorectal Cancer by Activating the miR-362-5p/HMGB3-Mediated Wnt/β-Catenin Signal Pathway
- Evaluation and optimization of deep learning models for enhanced detection of brain cancer using transmission optical microscopy of thin brain tissue samples
- Changes in the Gustave Roussy Immune Score as a Powerful Prognostic Marker of the Therapeutic Sensitivity of Nivolumab in Advanced Gastric Cancer: A Multicenter, Retrospective Study
- Impact of 68 Ga-PSMA PET on the Management of Patients with Prostate Cancer: A Systematic Review and Meta-analysis
- A Novel Hybrid Convolutional Neural Network for Accurate Organ Segmentation in 3D Head and Neck CT Images
- New 2-oxoindole derivatives as multiple PDGFRα/ß and VEGFR-2 tyrosine kinase inhibitors
- Introduction of human-centric AI assistant to aid radiologists for multimodal breast image classification
- Marine Mollusk‐Derived Agents with Antiproliferative Activity as Promising Anticancer Agents to Overcome Chemotherapy Resistance
- Evaluation of ASPM and TEF Gene Expressions as Potential Biomarkers for Bladder Cancer
- Cancer—Incidence, prevalence and mortality in the oldest-old. A comprehensive review
- Effect of Laparoscopic vs Open Distal Gastrectomy on 3-Year Disease-Free Survival in Patients With Locally Advanced Gastric Cancer
- Incidence and mortality of cancer in the Volta Region of Ghana
- Non-steroidal anti-inflammatory drug use and risk of endometrial cancer: A systematic review and meta-analysis of observational studies
- The role of the LOX family in cancer
- Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy
- Fermented dairy foods intake and risk of cancer
- Lung Cancer 2020
- Steroid metabolism in breast cancer: Where are we and what are we missing?
- Interventions for the treatment of oral and oropharyngeal cancers: surgical treatment
- Cervical cancer classification from Pap-smears using an enhanced fuzzy C-means algorithm
- A review of image analysis and machine learning techniques for automated cervical cancer screening from pap-smear images
- A pap-smear analysis tool (PAT) for detection of cervical cancer from pap-smear images
- Epidemiology of Human Papillomavirus–Positive Head and Neck Squamous Cell Carcinoma
- Tobacco Use and Effects of Professional Advice on Smoking Cessation among Youth in India
- Upregulation of CDK7 in gastric cancer cell promotes tumor cell proliferation and predicts poor prognosis
- Dietary fiber intake and reduced risk of ovarian cancer: a meta-analysis
- Antigen-specific active immunotherapy for ovarian cancer
- A prospective study of the safety and efficacy of liver stereotactic body radiotherapy in patients with and without prior liver-directed therapy
- Infratemporal Fossa Metastasis of Non-Small-Cell Lung Adenocarcinoma: A Case Report and Literature Review
- Diagnostic Accuracy of Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System (CEUS LI-RADS) for Differentiating Between Hepatocellular Carcinoma and Other Hepatic Malignancies in High-Risk Patients: A Meta-Analysis
- A modified staging of early and intermediate hepatocellular carcinoma based on single tumour >7 cm and multiple tumours beyond up‐to‐seven criteria
- Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society. [europepmc]
- Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy. [europepmc]
- Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial. [europepmc]
- Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis. [europepmc]
- Integrated genomic characterization of oesophageal carcinoma. [europepmc]
- Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma. [europepmc]
- Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions. [europepmc]
- Renal cell carcinoma. [europepmc]
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial. [europepmc]
- Oesophageal cancer. [europepmc]
- Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors. [europepmc]
- Direct detection of early-stage cancers using circulating tumor DNA. [europepmc]
- Deep Learning-Based Multi-Omics Integration Robustly Predicts Survival in Liver Cancer. [europepmc]
- Wild Mouse Gut Microbiota Promotes Host Fitness and Improves Disease Resistance. [europepmc]
- Cancer incidence and mortality in China, 2014. [europepmc]
- Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions. [europepmc]
- Molecular therapies and precision medicine for hepatocellular carcinoma. [europepmc]
- Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. [europepmc]
- Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway. [europepmc]
- Global Epidemiology of Lung Cancer. [europepmc]
- Tumor Microenvironment. [europepmc]
- Triple-negative breast cancer molecular subtyping and treatment progress. [europepmc]
- The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects. [europepmc]
- The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases. [europepmc]
- Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition). [europepmc]
Related